DSM commences tender offer for Kensey Nash
(Thomson Reuters ONE) -
Royal DSM (NYSE Euronext: DSM KON), the global Life Sciences and Materials
Sciences company, announced today that its indirect wholly-owned subsidiary,
Biomedical Acquisition Corporation, has commenced its previously announced
tender offer for all outstanding shares of common stock of Kensey Nash (NASDAQ:
KNSY) at a price of $38.50 per share (the "Offer").
The tender offer is being made in connection with the Agreement and Plan of
Merger, dated as of 2 May 2012, by and among DSM, Biomedical Acquisition
Corporation and Kensey Nash, which DSM and Kensey Nash announced on 3 May 2012.
The Kensey Nash board of directors has unanimously determined that, among other
things, the offer is fair to and in the best interests of Kensey Nash's
stockholders and unanimously recommends that Kensey Nash's stockholders accept
the offer and tender their shares.
The tender offer is scheduled to expire at 12:00 midnight (New York City time)
at the end of Monday, 18 June 2012, unless the offer is extended.
Complete terms and conditions of the tender offer are set forth in the Offer to
Purchase, Letter of Transmittal and other related materials that will be filed
by DSM and Biomedical Acquisition Corporation with the SEC on 21 May 2012. In
addition, on 21 May 2012, Kensey Nash will file a Solicitation/Recommendation
Statement on Schedule 14D-9 with the SEC relating to the offer. Copies of the
Offer to Purchase, Letter of Transmittal and other related materials are
available free of charge from MacKenzie Partners, Inc., the information agent
for the tender offer, toll-free at (800) 322-2885. The depositary for the tender
offer is Citibank, N.A.
Kensey Nash
Kensey Nash is a medical device company primarily focused on regenerative
medicine utilizing its proprietary collagen and synthetic polymer technology.
The company is recognized as a leader for innovative product development and
unique technology in the field of resorbable biomaterials. The company has an
extensive range of products, which are sold through strategic partners in
multiple medical markets, including the cardiology, orthopedic, sports medicine,
spine, trauma, craniomaxillofacial and general surgery markets. For more
information, visit http://www.kenseynash.com.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
22,000 employees deliver annual net sales of around ? 9 billion. The company is
listed on NYSE Euronext. More information can be found at www.dsm.com.
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Hans Vossen
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
fax +31 (0) 45 5740680 fax +31 (0) 10 4590275
e-mail media.relations(at)dsm.com e-mail investor.relations(at)dsm.com
Kensey Nash
Joseph W. Kaufmann
Tel. +1 484 713 2100
Press release-pdf:
http://hugin.info/130663/R/1613188/513653.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1613188]
Unternehmensinformation / Kurzprofil:
Datum: 21.05.2012 - 08:15 Uhr
Sprache: Deutsch
News-ID 148329
Anzahl Zeichen: 4519
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 211 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DSM commences tender offer for Kensey Nash"
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
